Cargando…
Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent Activation
The epidermal growth factor receptor (EGFR) is overexpressed or mutated in glioma. Recently, a series of missense mutations in the extracellular domain (ECD) of EGFR were reported in glioma patients. Some of these mutations clustered within a cysteine-rich region of the EGFR targeted by the therapeu...
Autores principales: | Ymer, Susie I., Greenall, Sameer A., Cvrljevic, Anna, Cao, Diana X., Donoghue, Jacqui F., Epa, V. Chandana, Scott, Andrew M., Adams, Timothy E., Johns, Terrance G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757403/ https://www.ncbi.nlm.nih.gov/pubmed/24212795 http://dx.doi.org/10.3390/cancers3022032 |
Ejemplares similares
-
Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3
por: Greenall, Sameer A., et al.
Publicado: (2018) -
EGFRvIII: the promiscuous mutation
por: Greenall, Sameer A, et al.
Publicado: (2016) -
Structural Model for the Interaction of a Designed Ankyrin Repeat Protein with the Human Epidermal Growth Factor Receptor 2
por: Epa, V. Chandana, et al.
Publicado: (2013) -
Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response
por: Donoghue, Jacqueline F., et al.
Publicado: (2018) -
A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors
por: Endersby, Raelene, et al.
Publicado: (2018)